Pancreatic Cancer Research

ResearcherUniversity of Occupational and Environmental Health JapanActive in the last 2 years

Daiki Uchihara

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1936-3998; OpenAlex author ID A5068900833. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2025: 1 paper · 2026: 2 papers

Papers 3

  1. Poorly differentiated clusters surpass tumor budding as novel prognostic factors in pancreatic cancer, especially in cases treated with neoadjuvant chemotherap… Co-author DOI 10.1186/s12876-026-04773-x↗
  2. Determinants of eligibility for second-line chemotherapy following gemcitabine plus nab-paclitaxel therapy in patients with unresectable pancreatic cancer: a r… Co-author DOI 10.1186/s12876-026-05075-y↗
  3. Long-chain fatty acyl CoA synthetase 4 expression in pancreatic cancer: a marker for malignant lesions and prognostic indicator for recurrence. Co-author DOI 10.1186/s13000-025-01659-6↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masaru Harada · 3 shared papers, 2025–2026 · strength 0.75
  2. Toshiyuki Nakayama · 2 shared papers, 2025–2026 · strength 0.49
  3. Nobuhiko Shinohara · 1 shared paper, 2026 · strength 0.26
  4. Tsuyoshi Ueda · 1 shared paper, 2026 · strength 0.26
  5. Yasuhisa Mori · 1 shared paper, 2026 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.